| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.WNEU.2019.12.001 |
| P698 | PubMed publication ID | 31821913 |
| P2093 | author name string | N Scott Litofsky | |
| Henok G Woldu | |||
| Sarah Travers | |||
| Courtney L Monroe | |||
| P2860 | cites work | Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma | Q27860910 |
| The epidemiology of glioma in adults: a "state of the science" review | Q28387839 | ||
| Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial | Q29547224 | ||
| Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support | Q29547407 | ||
| Pitfalls in the neuroimaging of glioblastoma in the era of antiangiogenic and immuno/targeted therapy - detecting illusive disease, defining response | Q30907831 | ||
| Surveillance CT scans are a source of anxiety and fear of recurrence in long-term lymphoma survivors | Q34231093 | ||
| Improving survival in recurrent medulloblastoma: earlier detection, better treatment or still an impasse? | Q36292414 | ||
| Oncological imaging: tumor surveillance in children | Q36429322 | ||
| Stress and intervention preferences of patients with brain tumors | Q36492137 | ||
| Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial | Q36914459 | ||
| Time trends in glioblastoma multiforme survival: the role of temozolomide. | Q37312701 | ||
| Postoperative surveillance magnetic resonance imaging for cerebellar astrocytoma. | Q37644397 | ||
| U.S. health care: a conundrum and a challenge | Q38058170 | ||
| What is the value of the routine use of patient-reported outcome measures toward improvement of patient outcomes, processes of care, and health service outcomes in cancer care? A systematic review of controlled trials. | Q38202943 | ||
| The role of targeted therapies in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline | Q38205134 | ||
| The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary | Q38829244 | ||
| European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas. | Q39291912 | ||
| Scan-associated distress in lung cancer: Quantifying the impact of "scanxiety". | Q40594040 | ||
| Medical technology in Canada, Germany, and the United States: an update | Q42595737 | ||
| Recurrent pediatric central nervous system low-grade gliomas: the role of surveillance neuroimaging in asymptomatic children | Q43569980 | ||
| Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment | Q45060789 | ||
| Supportive follow-up in patients treated with radical intent for high-grade glioma. | Q47205842 | ||
| Survival improvements with adjuvant therapy in patients with glioblastoma. | Q47267204 | ||
| SEOM clinical guidelines for diagnosis and treatment of glioblastoma (2017). | Q47994048 | ||
| Surveillance imaging and cost effectivity in pediatric brain tumors | Q48222555 | ||
| The role of surveillance magnetic resonance imaging (MRI) scanning in detecting recurrent brain tumors in asymptomatic children | Q48731921 | ||
| Surveillance scanning of children with medulloblastoma. | Q52883048 | ||
| Value of surveillance imaging in the management of medulloblastoma. | Q52936968 | ||
| The utility of routine surveillance screening with magnetic resonance imaging (MRI) to detect tumour recurrence in children with low-grade central nervous system (CNS) tumours: a systematic review. | Q55456734 | ||
| Asymptomatic recurrence detection with surveillance scanning in children with medulloblastoma. | Q55478529 | ||
| Health Care Spending in the United States and Other High-Income Countries | Q59444572 | ||
| Radiation Necrosis, Pseudoprogression, Pseudoresponse, and Tumor Recurrence: Imaging Challenges for the Evaluation of Treated Gliomas | Q60921507 | ||
| Personalised surveillance after treatment for high-risk cancer | Q61811954 | ||
| Screening for distress in patients with brain cancer using the NCCN's rapid screening measure | Q81527868 | ||
| Differentiating pseudoprogression from true progression: analysis of radiographic, biologic, and clinical clues in GBM | Q88690635 | ||
| Two-Year Survival Comparing Web-Based Symptom Monitoring vs Routine Surveillance Following Treatment for Lung Cancer | Q91154502 | ||
| cIMPACT-NOW update 3: recommended diagnostic criteria for "Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV" | Q91793916 | ||
| Survival Benefit of Maximal Resection for Glioblastoma Reoperation in the Temozolomide Era: A Meta-Analysis | Q92850681 | ||
| P304 | page(s) | e410-e417 | |
| P577 | publication date | 2019-12-09 | |
| P1433 | published in | World Neurosurgery | Q26853866 |
| P1476 | title | Does Surveillance-Detected Disease Progression Yield Superior Patient Outcomes in High-Grade Glioma? | |
| P478 | volume | 135 |
Search more.